EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
Active, not recruiting · NCT04921787 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Narcotic-Related Disorders, Neoplasms by Histologic Type, Substance Use Disorders, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-04-23 | NCT04921787 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gavin Bart | 1 |
| National Institute on Drug Abuse (NIDA) | 549 |
| The Emmes Company, LLC | 17 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston University | Boston | United States | 1 |
| Hennepin Healthcare Research Institute | Minneapolis | United States | 3 |
| New York University | New York | United States | 26 |
| Oregon Health & Science University | Portland | United States | 261 |